within Pharmacolibrary.Drugs.ATC.N;

model N02AA03
  extends Pharmacokinetic.Models.PK_1C_enteral(
    weight         = 70,
    F              = 0.32,
    Cl             = 3.266666666666666e-05,
    adminDuration  = 600,
    adminMass      = 8 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.00122,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01,
    ka             = 0.021333333333333333,
    Tlag           = 10.200000000000001
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>N02AA03</td></tr><td>route:</td><td>oral</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Hydromorphone is a potent opioid analgesic used to relieve moderate to severe pain. It acts primarily as a mu-opioid receptor agonist and is approved for use in many countries. Hydromorphone is available in various formulations including oral, intravenous, and rectal preparations. It is commonly used in both acute and chronic pain management, particularly in hospital settings.</p><h4>Pharmacokinetics</h4><p>Pharmacokinetic parameters reported for healthy adult volunteers following a single oral dose.</p><h4>References</h4><ol><li><p>Guay, DR (2010). Oral hydromorphone extended-release. <i>The Consultant pharmacist : the journal of the American Society of Consultant Pharmacists</i> 25(12) 816–828. DOI:<a href=\"https://doi.org/10.4140/TCP.n.2010.816\">10.4140/TCP.n.2010.816</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/21172762/\">https://pubmed.ncbi.nlm.nih.gov/21172762</a></p></li><li><p>Thigpen, JC, et al., &amp; Harirforoosh, S (2019). Opioids: A Review of Pharmacokinetics and Pharmacodynamics in Neonates, Infants, and Children. <i>European journal of drug metabolism and pharmacokinetics</i> 44(5) 591–609. DOI:<a href=\"https://doi.org/10.1007/s13318-019-00552-0\">10.1007/s13318-019-00552-0</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/31006834/\">https://pubmed.ncbi.nlm.nih.gov/31006834</a></p></li><li><p>Murray, A, &amp; Hagen, NA (2005). Hydromorphone. <i>Journal of pain and symptom management</i> 29(5 Suppl) S57–S66. DOI:<a href=\"https://doi.org/10.1016/j.jpainsymman.2005.01.007\">10.1016/j.jpainsymman.2005.01.007</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/15907647/\">https://pubmed.ncbi.nlm.nih.gov/15907647</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end N02AA03;
